Hendrix v. Novartis Pharmaceutical Corp.

ORDER GRANTING DEFENDANT NOVARTIS PHARMACEUTICALS CORPORATION’S MOTION FOR SUMMARY JUDGMENT [106]

MICHAEL W. FITZGERALD, District Judge.

This matter is before the Court on Defendant Novartis Pharmaceuticals Corporation’s (“NPC”) Motion for Summary Judgment (the “Motion”). (Docket No. 106). This case was assigned to this Court on March 19, 2013.

I. BACKGROUND

A. Undisputed Facts

Plaintiff Michel Hendrix was diagnosed with multiple myeloma in September 1999 by his oncologist, Dr. Berenson. (Plaintiffs Counter-Statement of Uncontroverted Facts (“PCUF”) ¶ 1). As part of his treatment for bone-related…